title: [The protective effects of melatonin on global cerebral ischemia-reperfusion injury in gerbils].
abstract: OBJECTIVE
  To investigate the effects of melatonin (MT) on histology and behavioral tests during global cerebral ischemia-reperfusion in gerbils.
  
  
  METHODS
  Global cerebral ischemia was induced by occluding the bilateral common carotid arteries for 10 min in gerbils. Three doses of MT were administrated intraperitoneally 30 min prior to the onset of ischemia. Locomotor activity was measured by using the open field method 3 and 7 days after the ischemic episode. T maze test was carried out 4, 5 and 6 days after ischemia to assess the working memory of gerbils. Neuronal damage was assessed in CA1 pyramidal layer of gerbil hippocampus and evaluated 7 days after ischemia.
  
  
  RESULTS
  MT significantly reversed the locomotor activity increases, ameliorated learning and working memory deficit, and reduced the extent of CA1 hippocampal pyramidal cells injury after transient global cerebral ischemia in the Mongolian gerbil.
  
  
  CONCLUSIONS
  MT provides significantly protective effect against both histological and behavioral consequences of global cerebral ischemia-reperfusion injury in gerbils.
authors.affiliation: Department of Pharmacology, Xuzhou Medical College, Xuzhou 221002, China.
authors.forename: Jing
authors.initials: J
authors.lastname: Zhang
authors.forename: Ji-dong
authors.initials: JD
authors.lastname: Guo
authors.forename: Shu-hua
authors.initials: SH
authors.lastname: Xing
authors.forename: Shu-ling
authors.initials: SL
authors.lastname: Gu
authors.forename: Ti-jun
authors.initials: TJ
authors.lastname: Dai
mesh_terms: D000818:Animals; D002545:Brain Ischemia / Q000150:complications; D005260:Female; D005849:Gerbillinae; D006624:Hippocampus / Q000187:drug effects* / Q000473:pathology; D007858:Learning / Q000187:drug effects; D008297:Male; D008550:Melatonin / Q000494:pharmacology / Q000627:therapeutic use*; D008568:Memory / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D011897:Random Allocation; D015427:Reperfusion Injury / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*
chemical_list: D018696:Neuroprotective Agents; D008550:Melatonin